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Severe Hemolytic Anemia in Patients With a Porcine
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Two patients underwent aortic valve replacement with
a porcine bleprosthesis. A few weeks later, both devel-
oped severe hemolytic anemia that could not be con-
trolled medically and led to additional valve replace-
Hemolysis is a common occurrence after the insertion of a
prosthetic heart valve and hemolytic anemia has been a
frequently described complication after the procedure (1-
4). Replacement of the aortic or mitral valve with a porcine
bioprosthesis, however, has rarely caused hemolysis (5,6)
or hemolytic anemia (7,8). We describe two patients with
severe hemolytic anemia after the placement of a porcine
heterograft in the aortic position. In both patients, aortic
regurgitation was due to perforation of the porcine hetero-
graft cusp. After replacement of the prosthetic valve, the
hemolytic anemia disappeared.
Case Reports
Case 1
A 68 year old white man underwent aortic valve replacement
with a 23 mm modified orifice Hancock porcine prosthesis and
single vessel coronary bypass graft. At the time of surgery, his
hemoglobin, red blood cell morphologic features and serum lactate
dehydrogenase (LDH) were normal. He was discharged after an
uneventful recovery, but saw his private physician several days
after leaving the hospital because of weakness. The hematocrit
was then noted to be 26%, and he was given a transfusion of 3
units of packed red blood cells. The hematocrit increased briefly
to 34%, but decreased to 31% several days later and then to 24%
the next week. He continued to note increasing fatigue and com-
plained of dark urine and jaundice. He was admitted to this center
I month postoperatively for evaluation.
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ment. In each case, perforation of the bioprosthetic cusps
was detected. This type of lesion was probably respon-
sible for this unusual complication in patients with an
aortic bioprosthesis.
On admission he was noted to be icteric, with a blood pressure
of 140/85 mm Hg. He was afebrile. Carotid upstrokes were normal.
The cardiac examination was remarkable for a grade 3/6 systolic
ejection murmur radiating to the neck; no diastolic murmur was
heard. There was no hepatosplenomegaly and 3 + pitting edema
of both legs was noted. Medications on admission included quin-
idine sulfate, digoxin, furosemide, folic acid, ferrous sulfate and
isosorbide dinitrate.
Laboratory data included a white blood count of 1O,100/mm.1
with a normal differential and a platelet count of 5oo,000/mm.1.
The hematocrit was 20.5% and the reticulocyte index was 10.1%.
The peripheral smear revealed severe schistocytosis, anisocytosis,
polychromasia and basophilic stippling. Electrolytes, urea nitrogen
and creatinine were normal. Urine dipstick was markedly positive
for blood, but only 0 to I red blood cells per high power field
were seen on microscopic examination. Serum haptoglobin was
undetectable. Total bilirubin was 3.0 mg/dl and direct bilirubin
0.5 mg/dl; serum LDH was 3,000 mU/ml. Multiple blood cultures
were negative. A Coombs' test (both direct and indirect) and su-
crose hemolysis test were negative.
Cardiac catheterization was performed and revealed a peak
aortic valve gradient of 22 mm Hg. The cardiac index was 3.2
liters/min per rrr'. Aortic root injection demonstrated a moderate
degree of aortic regurgitation. The patient required multiple trans-
fusions while hospitalized and had his valve replaced with a 25 mm
Carpentier-Edwards porcine bioprosthesis 2 months after his orig-
inal surgery. No perivalvular leak was seen at operation, but a
I mm? hole was found in one of the cusps. At the end of surgery,
his urine, which had been dark, was clear. The patient is currently
well 3 years after valve replacement without laboratory evidence
of hemolysis.
Case 2
A 69 year old white man with symptomatic aortic stenosis had
a fascia lata aortic valve implanted in 1969. He did well until
March 1982, when he began to notice increasing fatigue and dysp-
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nea on exertion. Physical examination was remarkable for a loud
murmur of aortic insufficiency. He underwent cardiac catheter-
ization which revealed severe aortic regurgitation with an elevated
left ventricular end-diastolic pressure. One month later, he was
admitted to New York University Medical Center where the orig-
inal prosthesis was replaced with a 25 mm Carpentier-Edwards
porcine bioprosthesis. Before surgery, hemoglobin, red blood cell
morphologic features and LDH were normal. At operation, the
leaflets of the prosthesis were fibrosed and retracted, leaving a
fixed opening in the center of the valve. He was discharged 2
weeks postoperatively after an uneventful recovery.
Two months postoperatively he began to complainof increasing
fatigue, dyspnea on exertion, orthopnea and pedal edema; he also
noted dark urine andjaundice. His hematocrit was 24%and despite
treatment with folate, iron and several transfusions, it remained
low. He was admitted to this center for evaluation.
At the time of admission, he was mildly icteric, with a blood
pressure of 140/84 mm Hg. He was afebrile. Carotid upstrokes
were brisk, with a palpable thrill. A grade 4/6 systolic ejection
murmur was heard over the left sternal border radiating toward
the carotid vessels, whilea grade 116 decrescendodiastolicmurmur
was heard along the left sternal border. There was no hepatosplen-
omegaly and 3+ pitting edema of both legs was noted. Medica-
tions included digoxin, sustained-release procainamide, furosem-
ide, ferrous sulfate and potassium chloride.
Laboratory studies revealed a hematocrit of 23% with a pe-
ripheral smear remarkable for marked schistocytosis and poikilo-
cytosis. The white blood cell count was 5,300/mm3 with 47%
neutrophils and 29% band forms; the platelet count was 201,000/
m", and the reticulocyte index was 6.9%. Serum haptoglobin was
undetectable. Total bilirubin was 3.0 mg/dl, direct bilirubin 0.4
mg/dl and LDH 3,070 mU/mI. Serum electrolytes, urea nitrogen
and creatinine were normal. Urine dipstick was positive for blood,
with no red blood cells seen on microscopicexamination. Multiple
blood cultures were negative, and direct and indirect Coombs'
tests were negative.
The patient underwent cardiac catheterization which revealed
a moderate degree of aortic regurgitation and a 40 mm Hg peak
systolic gradient across the aortic valve. He continued to require
almost daily transfusion, and 1 week after catheterization, under-
went repeat aortic valve replacement with a Bjork-Shiley pros-
thesis. At surgery, no valvular stenosisor outflowtract obstruction
was seen and no perivalvular leak was noted. A 2 x 2 mm hole
was found in one of the valve cusps (Fig. I). After surgery, his
urine became clear. Two weeks postoperatively, there was no
further hemolysis, as evidenced by a normal hematocrit, LDH and
red blood cell morphologic findings.
Discussion
Intravascular hemolysis is a common finding after pros-
thetic heart valve replacement. The prosthetic valve most
commonly associated with hemolysis is the cloth-covered
Starr-Edwards valve. Some degree of hemolysis was ob-
served in 67 to 100% of patients who had this type of valve
implanted (1-4). Frank hemolytic anemia is seen in ap-
proximately 5% of these patients (2). Other prosthetic heart
Figure 1. Case 2. Photograph showing the perforated porcine aortic bio-
prosthesis removed at surgery.
valves, including the Lillehei-Kaster and Bjork-Shiley tilt-
ing disc valves (4,9) and the Ionescu-Shiley pericardial xen-
ograft (9), cause hemolysis to a lesser degree. Hemolytic
anemia is also less common with these valves.
Causes of hemolysis. Several explanations for he-
molysis in the presence of a valvular prosthesis have been
advanced. The direct trauma to red blood cells striking for-
eign material within the circulation is believed to play a
major role. Turbulent blood flow or a high gradient with
large shearing stresses is also thought to be responsible (10).
The severe hemolysis often noted with perivalvular leaks is
probably due to the shearing forces accompanying the tur-
bulent flow present with such leaks. However, hemolysis
rarely occurs on malfunctioning native valves (5,6), even
though they are often severely stenotic or regurgitant, with
large gradients and much turbulence. This implies a greater
importance of the synthetic material itself in the production
of hemolysis. Porcine bioprostheses have been in wide-
spread use for over a decade, but hemolysis or hemolytic
anemia associated with these valves has rarely been re-
ported. Hemolysis appears to be very unusual even with
valve dysfunction that might be due to leaflet rupture, per-
foration or calcification.
Previous reports of hemolysis with porcine xeno-
grafts. A review of published data revealed two cases of
hemolytic anemia associated with porcine xenografts. The
first case of severe intravascular hemolysis associated with
a porcine prosthetic valve was reported in 1978 (7). The
patient had a Hancock porcine valve placed in the mitral
position and severe hemolysis was clearly documented I
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month postoperatively. Invasive and noninvasive evaluation
showed the valve to be functioning normally. The patient
was treated conservatively with folate and iron and 41/ 2
months postoperatively his hemolysis ceased spontaneously.
The marked improvement was believed to be secondary to
endothelialization of the valve's Dacron sewing ring.
A second case of severe hemolysis was reported in 1980
(8). A patient underwent aortic and mitral valve replacement
with Hancock porcine valves. He developed severe hemo-
lytic anemia 1 year postoperatively. At catheterization, mild
mitral regurgitation but no aortic regurgitation was seen.
Severe aortic prosthetic stenosis was identified (63 mm Hg
gradient); this was thought to be the primary cause of hem-
olysis. Both bioprostheses were replaced with Bjork-Shiley
prostheses, resolving the hemolysis. Although the leaflets
of the aortic valve xenograft were seen to be normal at
surgery, the struts of the valve had been compressed in-
wardly by a small aortic root, causing the large gradient.
Several studies have evaluated hemolysis in patients who
underwent valve replacement with porcine heterografts.
Roeser et al. (5), using chromium-51-labeled autologous
red blood cells, examined red blood cell survival in 30
patients 3 to 9 months after implantation of a porcine het-
erograft. Twenty-eight valves were placed in the aortic po-
sition and two in the mitral position. Twenty-three of these
patients had a normally functioning bioprosthesis and all
but one had normal red blood cell survival; the remaining
patient had a very mildly shortened red blood cell survival.
The other seven patients had varying degrees of aortic re-
gurgitation, ranging from minimal to moderately severe,
and all had evidence of shortened red blood cell survival.
None, however, had laboratory evidence of hemolytic ane-
mia. The authors concluded that porcine heterografts re-
sembled human valves in that they rarely produce clinical
hemolysis when either normal or malfunctioning. Recently,
Rao et al. (11) examined red blood cell survival in 10 pa-
tients who received a porcine bioprosthesis; 6 patients had
mitral valve replacement, 2 had aortic valve replacement
and 2 had both valves replaced. The valves in nine patients
functioned normally and their red blood cell survival was
normal. The remaining patient had moderate aortic regur-
gitation caused by a perivalvular leak and hemolysis was
documented by shortened red blood cell survival, schisto-
cytosis, reticulocytosis, lowered haptoglobin and anemia
(hemoglobin 10.1 g/dl).
Leaflet perforation as a cause of hemolysis. With re-
spect to hemolysis, porcine bioprostheses have character-
istics of native human valves: hemolytic anemia is very
uncommon, even with valve dysfunction. Our two patients
requiring almost continuous transfusions and eventually valve
replacement displayed a degree of hemolysis which rivals
that seen with mechanical prostheses. The reasons for the
severity of the hemolysis are unclear, although the leaflet
perforations that occurred shortly after implantation of these
porcine bioprostheses seem to be responsible for the hem-
olysis. The type of central leaflet perforation would conform
to a type III lesion, as described by Ishihara et al (12). This
type of lesion was shown to have ragged edges with exposed
collagen fibrils that may be responsible for turbulent flow
and shearing of the red blood cells.
In summary, although serious hemolytic anemia due to
porcine bioprosthesis is very uncommon, it does occur and
should be considered in the evaluation of unexplained ane-
mia in the porcine valve recipient.
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